Search Results 181-190 of 251 for ❣010라인인증 TG@KORID010 010어플가입인증❣

  1. Study of AMG 650 in Adult Participants With Advanced Solid Tumors - Mayo Clinic

    To evaluate the safety and tolerability of AMG 650 in adult participants and to determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D) ...

  2. A Study to Evaluate Topical VT30 to Treat Patients with Venous/Lymphatic Malformations Associated with PIK3CA or TEK Gene Mutations - Mayo Clinic

    Part 2 is a 12-week treatment, randomized, placebo-controlled, double-blind, safety and exploratory effectiveness study. Part 2 will be initiated only after the ...

  3. JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations - Mayo Clinic

    The purpose of this study is to evaluate JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway ...

  4. Z-Endoxifen Hydrochloride in Treating Patients with Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer - Mayo Clinic

    Hormone therapy using Z-endoxifen hydrochloride may fight breast cancer by blocking the use of estrogen by tumor cells. Participation eligibility. Participant ...

  5. A Study Assessing the Efficacy and Safety of 2 Dosage Regimens of Oral IPN60130 for FOP - Mayo Clinic

    Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare and severely disabling genetic disease characterized by heterotopic ossification (HO) in muscles, ...

  6. Relapse Prediction Following Discontinuation of Tocilizumab In Giant Cell Arteritis - Mayo Clinic

    In addition, this study will leverage the use of wearable technology (Oura ring) and machine learning to detect physiologic changes that can forecast flare in ...

  7. A Study to Evaluate the Safety and Effectiveness of Obeticholic Acid Treatment on People with Non-Alcoholic Steatohepatitis with Fibrosis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

    The purpose of this study is to assess the effectiveness of Revita® DMR for improving HbA1c to ≤ 7% without the need of insulin in subjects with T2D compared ...

  9. A Study Comparing the Safety and Effectiveness of Lonapegsomatropin with Placebo and Somatropin in Adults with Growth Hormone Deficiency - Mayo Clinic

    The purpose of this study is to evaluate the efficacy of once-weekly lonapegsomatropin compared to placebo at 38 weeks in adults with growth hormone deficiency ...

  10. A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...